Verofilcon A toric soft contact lenses
DeviceSoft contact lenses for optical correction of ametropia and astigmatism
Other names: PRECISION1™ for Astigmatism, P1fA
NCT Number: NCT05483127
The primary purpose of this study is to demonstrate noninferiority in the visual acuity at distance when wearing PRECISION1™ for Astigmatism (P1fA) soft contact lenses compared to another commercially available, soft toric contact lens, MyDay® toric (MDT).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kurata Eyecare Center, Los Angeles, California, United States
Study participants will wear each study lens type in 1 of 2 randomized, crossover sequences. Participants will be expected to attend 4 visits and wear study lenses for at least 10 hours per day. The total duration of an individual's participation in the study will be up to 28 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Soft contact lenses for optical correction of ametropia and astigmatism
Other names: PRECISION1™ for Astigmatism, P1fA
Soft contact lenses for optical correction of ametropia and astigmatism
Other names: MyDay® toric soft contact lenses, MDT
Time frame: Day 8 of each study lens type worn during the corresponding crossover period
Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05959200
Ametropia, Astigmatism
Oakland, California, United States
View Trial DetailsNCT03688672
Ametropia, Astigmatism
Columbus, Ohio, United States
View Trial DetailsNCT06165627
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial DetailsNCT01912768
Astigmatism, Eye Diseases
View Trial Details